Utilizing a foamy viral vector for engineering safer CD19CART cells

pVasileios Atsaves Emmanouel Simantirakis Ioannis Tsironis St Dunn; George Vassilopoulosp

DOI:10.4172/1948-5956-C1-160

Corpus ID: 196667020

Utilizing a foamy viral vector for engineering safer CD19CART cells

@inproceedings{Dunn2019UtilizingAF,
  title={Utilizing a foamy viral vector for engineering safer CD19CART cells},
  author={pVasileios Atsaves Emmanouel Simantirakis Ioannis Tsironis St Dunn and George Vassilopoulosp},
  year={2019}
}

pVasileios Atsaves Emmanouel Simantirakis Ioannis Tsironis St Dunn, George Vassilopoulosp

Published 2019

Biology

View via Publisher

Share This Paper

References

SHOWING 1-4 OF 4 REFERENCES

Retargeted Foamy Virus Vectors Integrate Less Frequently Near Proto-oncogenes

J. Hocum, I. Linde, D. Rae, Casey P. Collins, Lindsay K. Matern, G. Trobridge
Biology, Medicine
Scientific reports
2016

Gene therapy of primary T cell immunodeficiencies.

A. Fischer, S. Hacein-Bey-Abina, M. Cavazzana-Calvo
Medicine, Biology
Gene
2013

Foamy virus vector integration sites in normal human cells

G. Trobridge, D. Miller, +4 authors D. W. Russell
Biology, Medicine
Proceedings of the National Academy of Sciences of the United States of America
2006

LMO2-Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1

S. Hacein-Bey-Abina, C. von Kalle, +32 authors M. Cavazzana‐Calvo
Biology, Medicine
Science
2003

3,269

Utilizing a foamy viral vector for engineering safer CD19CART cells

References

Related Papers